RNF146 is a PAR-directed E3 ubiquitin ligase that recognizes and degrades activated PARP1 more efficiently than inactive PARP1 [2]; therefore, controlling RNF146 expression is a potential therapeutic strategy for treating PD. This evidence concerns the gene PRKN and Parkinson disease.